These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 309297)

  • 1. Biochemical, behavioral, and pharmacologic studies of the effects of dihydroxytryptamines in the rodent brain.
    Stewart RM; Gerson SC; Sperk G; Campbell A; Baldessarini RJ
    Ann N Y Acad Sci; 1978 Jun; 305():198-207. PubMed ID: 309297
    [No Abstract]   [Full Text] [Related]  

  • 2. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
    Pranzatelli MR; Snodgrass SR
    Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine.
    Colpaert FC; Koek W; Lategan A
    Eur J Pharmacol; 1989 Oct; 169(1):175-8. PubMed ID: 2513211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
    Ortmann R; Martin S; Waldmeier PC
    Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
    Pranzatelli MR; Dollison AM; Hlibczuk V
    Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-hydroxytryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat.
    Stewart RM; Growdon JH; Cancian D; Baldessarini RJ
    Neuropharmacology; 1976 Aug; 15(8):449-55. PubMed ID: 1086442
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats.
    Hoebel BG; Zemlan FP; Trulson ME; MacKenzie RG; DuCret RP; Norelli C
    Ann N Y Acad Sci; 1978 Jun; 305():590-4. PubMed ID: 152082
    [No Abstract]   [Full Text] [Related]  

  • 14. p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus.
    Pratt JA; Rothwell J; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():577-88. PubMed ID: 2418651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system.
    Stewart RM; Growdon JH; Cancian D; Baldessarini RJ
    Neurology; 1976 Jul; 26(7):690-2. PubMed ID: 1084496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of catecholamines on the central nervous system. (1). Role of dopamine in the brain in animal behavioral changes].
    Kameyama T; Kisara K
    Nihon Yakurigaku Zasshi; 1966 Sep; 62(5):317-26. PubMed ID: 5298294
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental study on central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA).
    Bo P; Camana C; Curti M; Fussi F; Giorgetti A; Savoldi F
    Farmaco Sci; 1988 Apr; 43(4):363-72. PubMed ID: 3264535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptophan-induced behaviour in guinea-pigs: its relevance to human myoclonus [proceedings].
    Chadwick D; Hallet M; Jenner P; Marsden CD
    Br J Clin Pharmacol; 1977 Jun; 4(3):402P-403P. PubMed ID: 302717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.